FDA campaign F-0275-2025
Class IHazard
potential contamination with E. coli O121:H19
Distribution
The firm distributed to seven (7) direct account consignees. Five(5) of those were distribution centers, two (2) were direct retail locations. States include NH, FL, CA, PA, MN, IL, NC, OH, PA,
REKALLD area-alert coverage: nationwide (our reading of the distribution above)
The text above is quoted verbatim from the FDA record. Confirm the affected units and the remedy with the manufacturer or FDA. Recall data may be incomplete, delayed, or superseded.